Skip to main content
Selvita S.A. logo

Selvita S.A. — Investor Relations & Filings

Ticker · SLV ISIN · PLSLVCR00029 LEI · 25940057WQ9YP5MOQF28 WAR Professional, scientific and technical activities
Open in API
Filings indexed 1,179 across all filing types
Latest filing 2021-12-14 Regulatory Filings
Country PL Poland
Listing WAR SLV

About Selvita S.A.

https://selvita.com/

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Recent filings

Filing Released Lang Actions
Otrzymanie istotnego zlecenia / Conclusion of a significant purchase order - Content (PL)
Regulatory Filings Classification · 97% confidence The document is a formal announcement by the Management Board of Selvita S.A. (Emitent) regarding the receipt of a significant purchase order (zlecenie) valued at over 1.1 million EUR. This announcement details a new contract/order related to R&D support, which impacts the company's business operations and financial outlook. This type of disclosure, reporting a material business contract or order, does not fit neatly into standard periodic reports (10-K, IR), specific financing events (CAP), or management changes (MANG). It is a specific, material business update. Given the options, it is closest to a general Regulatory Filing (RNS) as it is a required disclosure of a material event, or potentially a Capital/Financing Update (CAP) if the order is viewed as securing future revenue, but RNS is the most appropriate general category for material, non-standard operational news in this context, especially since it references a prior 'raport bieżący' (current report). Since it is a specific announcement of a material business event (a large contract), and not a standard financial report, RNS is the best fit as a general regulatory disclosure.
2021-12-14 Polish
SF_Selvita SA_Q3 2021_Pl
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for Selvita S.A. covering the period from January 1, 2021, to September 30, 2021. It includes a balance sheet, income statement, cash flow statement, and detailed accounting policies. Since it covers a period shorter than a full fiscal year (9 months) and contains substantive financial statements and analysis, it is classified as an Interim/Quarterly Report. 9M 2021
2021-11-24 Polish
SF_GK_Selvita_Q3 2021_ENG
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM CONSOLIDATED FINANCIAL STATEMENTS' for the period 01/01/2021 to 30/09/2021. It contains detailed financial tables, including the statement of comprehensive income, statement of financial position, and notes to the financial statements. This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data for a period shorter than a full fiscal year. 9M 2021
2021-11-24 English
SF_GK_Selvita_Q3_2021 PL
Interim / Quarterly Report Classification · 100% confidence The document is a 'Śródroczne skonsolidowane sprawozdanie finansowe' (Interim Consolidated Financial Statement) for Selvita S.A. covering the period from 01.01.2021 to 30.09.2021. It contains detailed financial statements (income statement, balance sheet, cash flow, etc.) and explanatory notes. As it is a comprehensive financial report for a period shorter than a full fiscal year, it falls under the 'Interim / Quarterly Report' category. 9M 2021
2021-11-24 Polish
Selvita_Raport_Q3_2021 ENG
Interim / Quarterly Report Classification · 100% confidence The document is a 'Consolidated Q3 2021 Report' for Selvita Capital Group. It contains detailed financial statements (balance sheet, profit and loss), management commentary, and operational updates for the nine-month period ending September 30, 2021. As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial data, it is classified as an Interim/Quarterly Report. 9M 2021
2021-11-24 English
Selvita_Raport_Q3_2021 PL
Interim / Quarterly Report Classification · 100% confidence The document is a 'Skonsolidowany Raport Kwartalny' (Consolidated Quarterly Report) for Q3 2021 for the Selvita Capital Group. It contains detailed financial statements, balance sheets, income statements, and management commentary on financial results. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. 9M 2021
2021-11-24 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.